drugset / Trial / NCT01436994

Antithyroid Drug Treatment of Thyrotoxicosis in Young People

NCT01436994

Phase 3 Completed 81 enrolled Newcastle-upon-Tyne Hospitals NHS Trust
RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators aim to establish whether biochemical control during anti-thyroid drug therapy in young people with thyrotoxicosis varies depending upon whether a 'block and replace' or 'dose titration' regimen is used. The investigators will also assess remission rates and the frequency of side-effects in the two treatment groups.

Timeline

Start
2004-07
Primary completion
2014-12
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carbimazole Small molecule 0.25 mg/kg
Comparator Carbimazole Small molecule 0.75 mg/kg
Comparator Levothyroxine Other / unclassified
Comparator Propylthiouracil Small molecule